SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950142-22-001847
Filing Date
2022-06-08
Accepted
2022-06-08 08:01:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 eh220259893_424b3-201.htm 424B3 40737
2 GRAPHIC company_logo.jpg GRAPHIC 10406
  Complete submission text file 0000950142-22-001847.txt   50916
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-264201 | Film No.: 221002618
SIC: 2834 Pharmaceutical Preparations